C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: Differential effect of T lymphocyte-derived cytokines

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 530-536

  Kolios, George ^a   Wright, Karen L ^a   Jordan, Nicola J ^a   Leithead, Jane B ^a   Robertson, Duncan A F ^b   Westwick, John ^a  

^a University of Bath   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Chemokine; Colonic epithelial cell; HT 29 cell; Intestinal inflammation; T lymphocyte

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ARTICLE; CELL LINE; COLON MUCOSA; CONTROLLED STUDY; ENTERITIS; EPITHELIUM CELL; HUMAN CELL; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

CELL COMMUNICATION; CELL LINE; CHEMOKINES, CC; CHEMOKINES, CXC; COLON; CYTOKINES; EPITHELIAL CELLS; HUMANS; IMMUNITY, MUCOSAL; T-LYMPHOCYTES;

EID: 0032989464     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<530::AID-IMMU530>3.0.CO;2-Y     Document Type: Article

References (30)

1. Mowat, A. M. and Viney, J. L., The anatomical basis of intestinal immunity. Immunol. Rev. 1997. 156: 145-166.
2. Christ, A. D. and Blumberg, R. S., The intestinal epithelial cell: immunological aspects. Springer Semin. Immunopathol. 1997. 18: 449-461.
3. Lindley, I. J. D., Westwick, J. and Kunkel, S. L., Nomenclature announcement - the chemokines. Immunol. Today 1993. 14: 24.
4. Rollins, B. J., Chemokines. Blood 1997. 90: 909-928.
5. Mitsuyama, K., Toyonaga, A., Sasaki, E., Watanabe, K., Tateishi, H., Nishiyama, T., Saiki, T., Ikeda, H., Tsuruta, O. and Tanikawa, K., IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 1994. 96: 432-436.
6. Grimm, M. C. and Doe, W. F., Chemokines in inflammatory bowel disease mucosa. Expression of RANTES, Macrophage Inflammatory Protein (MIP)-1-alpha, MIP-1-beta, and Gamma Interferon Inducible Protein-10 by macrophages, lymphocytes, endothelial cells and granulomas. Inflamm. Bowel Dis. 1996. 2: 88-96.
7. Boismenu, R., Feng, L., Xia, Y. Y., Chang, J. C. C. and Havran, W. L., Chemokine expression by intraepithelial gamma/delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J. Immunol. 1996. 157: 985-992.
8. Kolios, G., Robertson, D. A. F., Jordan, N. J., Minty, A., Caput, D., Ferrara, P. and Westwick, J., Interleukin-8 production by the human colon epithelial cell line HT-29: Modulation by interleukin 13. Br. J. Pharmacol. 1996. 119: 351-359.
9. Jung, H. C., Eckmann, L., Yang, S. K., Panja, A., Fierer, J., Morzycka-Wroblewska, E. and Kagnoff, M. F. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 1995. 95: 55-65.
10. Mazzucchelli, L., Hauser, C., Zgraggen, K., Wagner, H. E., Hess, M. W., Laissue, J. A. and Mueller, C., Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J. Pathol. 1996. 178: 201-206.
11. Roth, S. J., Diacovo, T. G., Brenner, M. B., Rosat, J. P., Buccola, J., Morita, C. T. and Springer, T. A., Transendothelial chemotaxis of human α/β and γ/δ T lymphocytes to chemokines. Eur. J. Immunol. 1998. 28: 104-113.
12. Sartor, R. B., Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994. 106: 533-539.
13. Minty, A., Chalon, P., Derocq, J.-M., Dumont, X., Guillemot, J.-C., Kaghad, M., Labit, C., Leplatois, P., Liauzan, P., Miloux, B., Minty, C., Casse;;as, P., Loison, G., Lupker, J., Shire, D., Ferrara, P. and Caput, D., Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993. 362: 248-250.
14. Zurawski, G. and De Vries, J. E., Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells, Immunol. Today 1994. 15: 19-26.
15. Moore, K. W., O'Garra, A., De Waal Malefyt, R., Vieira, P. and Mosmann, T. R., Interleukin-10. Annu. Rev. Immunol. 1993. 11: 165-190.
16. Niessner, M. and Volk, B. A., Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 1995. 101: 428-435.
17. Radford-Smith, D. and Jewell, D. P., Cytokines and inflammatory bowel disease. Bailliere's Clinical Gastroenterology 1996. 10: 151-164.
18. Kucharzik, T., Lugering, N., Weigelt, H., Adolf, M., Domschke, W. and Stoll, R., Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease. Comparison with IL-4 and IL-10. Clin. Exp. Immunol. 1996. 104: 483-490.
19. Kucharzik, T., Lugering, N., Adolf, M., Domschke, W. and Stoll, R., Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig. Dis. Sci. 1997. 42: 805-812.
20. Kahn, R., Lohler, J., Rennick, D., Rajewsky, K. and Müller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993. 75: 263-274.
21. Wright, K. L., Ward, S. G., Kolios, G. and Westwick, J., Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J. Biol. Chem. 1997. 272: 12626-12633.
22. Grimm, M. C., Elsbury, S. K. O., Pavli, P. and Doe, W. F., Enhanced expression and production of Monocyte Chemoattractant Protein-1 in inflammatory bowel disease mucosa. J. Leukoc. Biol. 1996. 59: 804-812.
23. 4 analogs. J. Clin. Invest. 1998. 101: 1860-1869.
24. Greenewald, B. D. and James, S. P., Immunology of inflammatory bowel disease. Curr. Opin. Gastroenterol. 1995. 11: 298-304.
25. Kucharzik, T., Lugering, N., Stoll, R. and Domschke, W., IL-4, IL-10, and IL-13 reveal strong capacity to downregulate MCP-1 and GM-CSF in activated intestinal epithelial cells. Gut 1997. 40: F296.
26. Saura, M., Martinez-Dalmau, R., Minty, A., Perez-Sala, D. and Lamas, S., Interleukin-13 inhibits inducible nitric oxide expression in human mesangial cells. Biochem. J. 1996. 313: 641-646.
27. Kolios, G., Rooney, N., Murphy, C. T., Robertson, D. A. F. and Westwick, J., Expression of inducible nitric oxide synthase (iNOS) activity in human colon epithelial cells: Modulation by T-lymphocyte derived cytokines. Gut 1998. 43: 56-63.
28. Ebert, E. C., Human intestinal intraepithelial lymphocytes have potent chemotactic activity. Gastroenterology 1995. 109: 1154-1159.
29. Schreiber, S., Heinig, T., Panzer, U., Reinking, R., Bouchard, A., Stahl, P. D. and Raedler, A., Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 1995. 108: 21-33.
30. Yoshimura, T., Takeya, M. and Takahashi, K., Production and characterization of mouse monoclonal antibodies against human MCP-1. J. Immunol. 1991. 147: 2229-2233.